Lung Ultrasound to Evaluate Invasive Fungal Diseases after Allogeneic Hematopoietic Stem Cell Transplantation
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Invasive fungal diseases (IFDs) are a leading cause of infection-related-mortality after allogeneic hematopoietic stem cell transplantation (HSCT). In this prospective pilot study, we investigated the use of bedside lung ultrasound (US) in IFD management. Ten consecutive hematological patients, who developed pulmonary IFD after HSCT, were included in the study. Standard computed tomography scan and lung US were performed at IFD diagnosis and 10 days after antifungal treatment. The lung US demonstrated a high sensitivity in the detection of lung lesions at IFD diagnosis and in the follow-up examinations. It is of potential clinical relevance for IFD management in hematological patients.
Abstract
Invasive fungal diseases (IFDs) are a leading cause of infection-related-mortality after allogeneic hematopoietic stem cell transplantation (HSCT). In this prospective pilot study, we investigated the use of bedside lung ultrasound (US) in IFD management. Ten consecutive hematological patients, who developed pulmonary IFD after HSCT, were included in the study. Standard computed tomography scan and lung US were performed at IFD diagnosis and 10 days after antifungal treatment. The lung US demonstrated a high sensitivity in the detection of lung lesions at IFD diagnosis and in the follow-up examinations. It is of potential clinical relevance for IFD management in hematological patients.
참고문헌 (14)
- Girmenia C, "Incidence and outcome of invasive fungal diseases after allogeneic stem cell transplantation : a prospective study of the Gruppo Italiano Trapianto Midollo Osseo(GITMO)", Biol Blood Marrow Transplant, 20, pp.872~880 (2014)
- Gratwohl A, "Cause of death after allogeneic haematopoietic stem cell transplantation (HSCT) in early leukaemias: an EBMT analysis of lethal infectious complications and changes over calendar time", Bone Marrow Transplant, 36, pp.757~769 (2005)
- De Pauw B, "Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer", Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group(EORTC, Clin Infect Dis, pp.2008, 46[DOI]
- Metlay JP, "Testing strategies in the initial management of patients with community-acquired pneumonia", Ann Intern Med, 138, pp.109~118 (2003)
- Albaum MN, "Interobserver reliability of the chest radiograph in community-acquired pneumonia. PORT Investigators", Chest, 110, pp.343~350 (1996)
- Syrjälä H, "High-resolution computed tomography for the diagnosis of community-acquired pneumonia", Clin Infect Dis, 27, pp.358~363 (1998)
- Beckh S, "Real-time chest ultrasonography : a comprehensive review for the pulmonologist", Chest, 122, pp.1759~1773 (2002)
- Kimura BJ, "Cardiopulmonary limited ultrasound examination for"quick-look"bedside application", Am J Cardiol, 108, pp.586~590 (2011)
- Lichtenstein DA, "Ultrasound diagnosis of alveolar consolidation in the critically ill", Intensive Care Med, 30, pp.276~281 (2004)
- Lichtenstein D, "The comet-tail artifact. An ultrasound sign of alveolar-interstitial syndrome", Am J Respir Crit Care Med, 156, pp.1640~1646 (1997)
- Greco R, "Posttransplantation cyclophosphamide and sirolimus for prevention of GVHD after HLA-matched PBSC transplantation", Blood, 128, pp.1528~1531 (2016)
- Cieri N, "Post-transplantation cyclophosphamide and sirolimus after haploidentical hematopoietic stem cell transplantation using a treosulfan-based myeloablative conditioning and peripheral blood stem cells", Biol Blood Marrow Transplant, 21, pp.1506~1514 (2015)
- Reissig A, "Lung ultrasound in the diagnosis and follow-up of community-acquired pneumonia: a prospective, multicenter, diagnostic accuracy study", Chest, 142, pp.965~972 (2012)
- Girmenia C, "Breakthrough invasive fungal diseases in acute myeloid leukemia patients receiving mould active triazole primary prophylaxis after intensive chemotherapy: An Italian consensus agreement on definitions and management", Med Mycol, 57(Suppl 2), pp.S127~S137 (2019)